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Abstract New protocols and instrumentation signiﬁ-
cantly boost the outcome of structural biology, which has
resulted in signiﬁcant growth in the number of deposited
Protein Data Bank structures. However, even an enormous
increase of the productivity of a single step of the structure
determination process may not signiﬁcantly shorten the
time between clone and deposition or publication. For
example, in a medium size laboratory equipped with the
LabDB and HKL-3000 systems, we show that automation
of some (and integration of all) steps of the X-ray structure
determination pathway is critical for laboratory produc-
tivity. Moreover, we show that the lag period after which
the impact of a technology change is observed is longer
than expected.
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Abbreviations
ALS Advanced Light Source
CDP Cytidine-50-diphosphate
CSGID Center of Structural Genomics for Infectious
Diseases
MCSG Midwest Center for Structural Genomics
NSLS National Synchrotron Light Source
PDB Protein Data Bank
SG Structural genomics
SGC Structural Genomics Consortium
Introduction
During last 10 years, several high throughput—and even
high output—structure determination pipelines (mostly
using X-ray diffraction methods) were developed by a
number of multi-institutional consortia. They all share the
same goal: rapid progress from the cloning of a protein
gene to the determination and deposition of its structure
into the Protein Data Bank (PDB) [1].
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DOI 10.1007/s10969-010-9092-9The most productive X-ray crystallography pipelines
established by some structural genomics (SG) groups are
capable of depositing 200 structures per year. This rate of
structure determination would not be possible without the
substantial effort that these groups put into optimization and
automation of all stages of the structure determination
process: cloning, expression, puriﬁcation, crystallization,
data collection, processing, phasing, model building,
structure reﬁnement, validation and deposition. While the
whole process is not yet fully automated, both hardware and
software tools and protocols have been developed to par-
tially or fully automate nearly every stage of the process.
In contradiction to anecdotal experience, it has been
shown that there is no clear single bottleneck in the
structure determination process [2], except perhaps at
the point when it is necessary to engage the brain of the
researcher. The most productive SG centers developed
signiﬁcant automation of the structure elucidation process.
In many cases in this automated environment, the ﬁrst time
when the researcher’s brain is fully engaged is the bio-
logical interpretation of the 3-D protein structure, i.e. the
process of analysis of data, integrating results and writing
the publication.
As the analysis and description of the relationship
between a protein’s structure and function has not yet been
automated, the most successful SG groups publish only a
fraction of their structures in peer-reviewed journals.
However, high-impact research has been published by SG
groups. An analysis of PDB data shows that out of 6,955
structures reported by SG centers around the world since
2005, 3.7% of those structures were reported in the high-
impact journals Nature, Science, Cell and PNAS.
We describe our automation protocols to improve the
efﬁciency of various steps of the high-throughput structure
determination pipeline, as a part of our work in both the
Center of Structural Genomics of Infectious Diseases
(CSGID) and the Midwest Center for Structural Genomics
(MCSG). In particular, we present and discuss automation
andprotocolsthatareapplicabletoasmall-ormedium-sized
laboratory, such as the one at University of Virginia. The
majority of structures solved by these consortia were
determinedbymeansofX-raycrystallography,thoughother
methods such as NMR may be used in high-throughput
structuredetermination.Asourautomationexperiencedeals
almost exclusively with the X-ray crystallography pipeline,
we will focus on this technique in this work.
Automation of cloning, expression, puriﬁcation
and crystallization
It is evident that the production of diffraction-quality
macromolecular crystals is the most challenging and
expensive step in the process that leads to determination of
the macromolecular structure. The four steps are tightly
linked to one another and should be treated as a single
process leading to high-quality crystals. Seldom are
expressed recombinant proteins soluble, puriﬁcation
straightforward, and diffraction-quality crystals obtained
with only initial screening. In reality, each step has to be
performed several times. For example, the Structural
Genomics Consortium (SGC) reports the use (on average)
of *20 different constructs for each single successful
structure determination process [3].
In practice, many automation tools have been developed
for virtually all steps of the protein production and crys-
tallization pipeline. For example, cloning and expression
has been automated using technologies such as ligation-
independent cloning methods [4] and Biomek/Multimek
(Beckman Coulter) liquid handling systems [5]. Protein
puriﬁcation has been automated by a number of groups
using high-capacity liquid chromatography systems, such
as the AKTA Express (GE Healthcare) series of instru-
ments, e.g. [6–8].
As (arguably) the most labor-intensive part of the pro-
cess, high-throughput crystallization and crystal observa-
tion has spawned many automation technologies, most of
which are commercially available. These include liquid
handling systems for preparation of custom crystallization
formulations like the Alchemist II (Rigaku), Biomek
(Beckman-Coulter), Matrix Maker (Emerald BioSystems),
and Freedom EVO (Tecan); plate setup robots like the
Phoenix RE (Art Robbins/Rigaku) and Mosquito (TTP
LabTech); plate observation systems like the Minstrel
(Rigaku), CrystalFarm (Bruker), and CrystalPro (Tritek);
and even crystal harvesting robots such as the Crystal
Harvester (Bruker) [9, 10].
The most difﬁcult part of this process is the connection
of these disparate components into an integrated workﬂow
[11]. In addition, the degree various steps in the protein
production and crystallization pipeline should be partially
or fully automated depends on an analysis of the bottle-
necks, impact and cost. Some steps, especially the prepa-
ration and observation of crystallization plates almost
always demands automation of some kind. However, in
small or moderate-size operations, such as a single-prin-
cipal investigator laboratory, fully automated cloning and
expression methods are not necessary, as more traditional
methods of expression (e.g., in regular 1–3 L fermentation
ﬂasks) may be used. However, some way of integrating and
managing data from a blend of manual and automated
approaches is necessary.
The LabDB system is the central database which tracks
cloning, expression, puriﬁcation, and crystallization experi-
mentsinourlaboratory.AschematicoftheLabDBsystemis
presented in Fig. 1. LabDB is designed to input information
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123both from manual entry and from automated systems. The
manual components are the PHP-based web interface for
LabDB and the Xtaldb system [12].
The cloning and expression pipeline in the laboratory is
largely not automated, and thus data for these types of
experiments are entered mostly by hand into the database.
However, one chromatography step of the puriﬁcation
process is integrated into the LabDB system by a custom
module that imports information directly from the AKTA’s
UNICORN software system. Every time a chromato-
graphic separation is executed, detailed information about
the process, including the chromatogram, peak heights, etc.
is imported into the system.
The Xtaldb [12] component of LabDB contains an
interface for semiautomatically adding images and anno-
tating crystallization drops. Recently, we have developed a
module to automatically import into LabDB images and
drop annotations made automatically by a Minstrel HT
(Rigaku, Inc) system, by communicating with the Crys-
talTrak database (Rigaku, Inc.). The laboratory in Virginia
also makes use of a Mosquito dispensing robot (TTP
Labtech, LLC.) and other tools like multichannel pipetters
to semiautomatically generate initial 96-well crystallization
plates. However, automation does introduce serious limi-
tations, as only crystallization plates compatible with the
robots—typically those with the standard 96-well Society
for Biomolecular Sciences (SBS) microplate footprint—
may be used.
The process of crystal growth optimization in our
laboratory, on the other hand, is largely done manually, in
24-well plates. A number of large, high-throughput SG labs
also tend to use automatic processes for setting up initial
screens of protein but the process of optimization is largely
done by hand. A fair amount of effort has been put into
generating customized crystallization screens, identifying
optimized conditions proven successful for several other
proteins. Some of the optimized screens have subsequently
been commercialized and have joined the ranks of more
‘‘traditional’’ sets of screens e.g., the JCSG Core [13], and
JCSG ? [14] screens (QIAGEN, Inc.).
Crystallization optimization is also difﬁcult to automate
because often changes need to be made to the recalcitrant
protein itself in order to get it to crystallize. Some protocols
have been developed to approach this problem in at least a
semiautomatic way: e.g. limited proteolysis [3, 15], protein
methylation [16, 17] (see also Fan & Joachimiak, this
issue), automated domain design (Babnigg and Joachimiak,
this issue; and http://bioinformatics.anl.gov/cgi-bin/tools/
pdpredictor) and additive screening [18]. The latter pro-
cedure, in addition to potentially enhancing the crystalli-
zation of a target protein, can also provide important
information about the function and/or mechanism of a
protein in the absence of other biochemical information.
Other approaches require returning to a prior step in the
pipeline, such as the generation of alternative constructs
including e.g. surface entropy reduction [19].
Fig. 1 A schematic overview
of the LabDB system. The four
components of the system are
shown connected by solid
arrows, while laboratory
systems from which data are
automatically extracted are
shown connected by dotted lines
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123The Wetlab component of the LabDB system does little
to automate the actual work of the production of stock
solutions of chemicals, but it does automate, with a much
greater level of detail, the record-keeping associated with
chemical stocks and stock solutions. Every bottle of a
reagent is entered into a database, and by using a balance,
pH meter, and barcode printer connected by a port server
directly to the LabDB database, the process of labeling and
recording prepared stock solutions is automated. This is
especially advantageous in that every stock solution is
annotated with information that is not ordinarily included
whenever such a solution is prepared by hand: e.g., the lot
number of the chemical, the date it was received, etc.
Information in LabDB about the cloning, expression,
puriﬁcation, and crystallization of CSGID and MCSG
projects are transferred to the central databases for these
SG efforts by means of XML ﬁles. The XML formats,
which list details of each kind of experiment, are speciﬁed
by means of XML Schema documents. These speciﬁca-
tions may be used to validate a given XML ﬁle for syn-
tactic correctness. An automated script queries the LabDB
database, generates the ﬁle and places it in a publicly
accessible location. These ﬁles are then downloaded reg-
ularly by the CSGID and MCSG databases, parsed, and
their experimental information is imported.
The choice of the best path (or protocol) for navigating
the protein production and crystallization pathway, partic-
ularly given that information must be integrated from both
manual and automatic sources, is a difﬁcult one that con-
sumes time and money.
Data collection and structure solution
Currently there are over 125 synchrotron stations in the
world that are suitable for (and many are dedicated for)
X-ray macromolecular diffraction experiments. In recent
years, over 80% of PDB deposits report the use of a syn-
chrotron source for diffraction experiments [20]. In com-
parison with experiments performed only 20 years ago,
even the simplest synchrotron stations are highly
automated.
The automation was possible thanks to both hardware
and software developments at the beamlines. Software
development is especially important in integration of dif-
ferent hardware components and enhancement of the
researcher’s ability to control the diffraction experiment. In
most cases the experimenter uses a single, usually user-
friendly interface [21]. Moreover, such software allows for
remote data collection, and thanks to this software, so-
called ‘mail-in’ crystallography is becoming more popular
[22, 23]. The ability to collect data from distant locations
via remote access to synchrotron beamlines would be not
possible without development of robotic systems for stor-
ing and mounting of crystals [24]. Thus a lot of effort has
been put into development of such systems [25, 26]. Cur-
rently automatic mounting systems are available from
commercial suppliers and in many cases are standard
additions to home diffractometers. The solution of prob-
lems connected with crystal mounting and centering leads
to the development of fully automated beamlines and dif-
fractometers which are very useful for extensive crystal-
lographic screening of potential small-molecule ligands.
Although fully automated systems are capable of high-
throughput crystal mounting and data collection, their
application does not necessarily instantly and substantially
impact the productivity of a synchrotron station (Fig. 2).
Even though the diffraction experiment seems to be rela-
tively simple, the fact that the experimenter has limited
control of crystal quality can make automation of data
collection very challenging. Problems with automation
start at the beginning of the diffraction experiment:
namely, with crystal centering. Centering is not always
simple even for humans, therefore the process may be quite
difﬁcult to automate, especially for samples which are
suboptimally cryocooled or if the crystals are very small
[27]. In such cases, centering may require the use of X-ray
or UV radiation [28, 29]. Once the crystal is well centered,
its quality has to be evaluated and scored. This step of the
data collection process is the most critical, as the strategy
of the best diffraction intensity recording protocol is based
on initial diffraction images. The correct determination of
crystal symmetry, unit cell parameters, mosaicity, and
estimation of the crystal’s survival time in an X-ray beam
with a particular wavelength and intensity, all very strongly
affect the quality of the data, and therefore the quality of
the subsequent crystal structure. Moreover, proper mea-
surement of the strongest intensities is very important for
the choice of strategy during collection of data used for
structure solution in both MR and SAD/MAD methods
[30].
Successful structure solution and reﬁnement are the best
validation methods of the data collection process. Having
this in mind, automatic or semiautomatic systems used
during the structure determination process should be
designed to provide the best possible structures, not just the
best data sets. So, ideally the structure solution process
should be done in parallel with data processing. HKL-3000
[31], through the integration of data collection, processing,
structure solution and reﬁnement, provides the researcher
in many cases with an initial model of the structure, when
the crystal is still on the goniostat. The HKL-3000 pipeline
incorporates many formidable and widely used programs
like CCP4 [32], SOLVE [33], RESOLVE [34], MLPHARE
[35], SHELXD and SHELXE [36], ARP/wARP [37], DM
[38], MOLREP [39], REFMAC [40], and Molprobity [41].
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experimenter the ability to check the most important
parameters deﬁning the quality of the diffraction data and
gives insight into the particular steps of the structure elu-
cidation process, which is divided into six steps [31]. In
most cases, using the default settings of the program
through these six steps (the ‘‘six click’’ approach) in HKL-
3000 results in a highly complete model of a macromole-
cule. Moreover, such a semiautomatic pipeline of structure
determination at every step provides feedback to the
experimenter and in the worst case shows why a particular
experiment failed, which is not possible in the case of
‘‘brute force’’ automation.
Counterintuitively, the failure of the system to generate
a satisfactory model of a given structure is very beneﬁcial
for developmental work on difﬁcult cases that cannot be
solved by standard approaches, and often leads to
improvement of the semi-automated algorithms [42]. When
a stubborn structure is successfully built and reﬁned, it is
used a posteriori as a test case. Speciﬁcally, parameters of
the structure solution are varied, and the settings that
produce the ‘‘best’’ initial electron density map (as mea-
sured by correlation of the map to the ﬁnal reﬁned model)
are incorporated into the structure solution pipeline.
Sometimes projects that seem to be very easy may in
fact turn out to be very challenging. Despite having a data
set of reasonable quality and properly determined space
group, the structure solution or model building occasion-
ally fails for unknown reasons. Our experience shows that
most cases are caused by mislabeling of the crystals (or
even the proteins used for the crystallization) and as a
result the wrong sequence is provided to the structure
determination pipeline, causing an unnecessary waste of
time. In similar cases the ‘‘brute force’’ approach may be
the only way to successfully overcome problem due to an
incorrect polypeptide sequence. For example, systems like
BALBES [43] or MrBUMP [44] may efﬁciently try many
different models [45] and hopefully return a proper solu-
tion. In truly ‘‘hopeless’’ cases, the use of thousands of
models may be necessary [46]. However, a simple check of
the unit cell parameters and their comparison with unit cell
parameters reported in the PDB may immediately show
that instead of a Nobel-prize-winning molecule, the
experimenter may have crystallized glutathione S-trans-
ferase (GST), or some other well known component of the
expression system. If the map is of sufﬁciently high reso-
lution and quality, and the automatic model building
algorithm builds the polypeptide backbone but unexpect-
edly fails to assign sequence, it may be possible to use the
density itself to sequence a fragment of the protein and use
that fragment to search for the correct protein in sequence
databases.
The data collection is the last experimental step in the
crystal structure determination process, and errors made at
this step may nullify successful work from several prior
steps. Therefore it is worth immediately checking the
results of this process. In our practice (3–4 ‘‘synchrotron
trips’’ per year, *1,200 crystals screened, and *600
datasets collected), we noticed that in order to maximize
productivity of data collection it is worth taking some
crystals still present in crystallization plates. Usually we
begin data collection using pre-cryocooled crystals and
immediately proceed to structure solution, if possible.
Dependent on the initial results, the next crystals from the
same project will be screened to search for a higher reso-
lution dataset, but if one is not found, we are able to search
for improved soaks conditions while still at the synchro-
tron. In this process HKL-3000 plays a central role. HKL-
3000, in connection with HKLdb, contains all information
necessary for efﬁcient data collection and structure solu-
tion. Information on the crystals which are placed in the
X-ray beam are linked to the crystallization database
(Xtaldb), from which one may retrieve information on
compounds used for soaking experiments (for example).
Fig. 2 A Number of data sets collected and structures deposited for
beamline 5.0.2 at ALS. The green arrow indicates the introduction of
an automatic crystal mounting system. B Number of datasets
collected and structures deposited for beamline X4A at NSLS. The
green arrow indicates introduction of an automatic image plate
detector, and the purple line marks introduction of a CCD detector
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electron density maps rapidly, which may be used to
determine if the structure contains a bound small molecular
agent. This approach leaves time to concentrate on stub-
born projects, as less difﬁcult ones are quickly classiﬁed as
‘‘solvable’’ and ‘‘reﬁneable.’’
Ligand screening and identiﬁcation
In many cases, the structures of the apo-forms of proteins
provide limited information about protein mechanism of
action. For that reason, most biologists, biochemists and
drug developers are interested ultimately in gaining
insights into interactions of the protein with ligands and
effectors related to the protein function or the regulation
thereof. The direct approach to obtain this information is
the determination and analysis of the holo-forms of protein
structures. Apart from a few lucky cases where bound
ligand is retained by the protein throughout puriﬁcation and
crystallization, there are two ways to obtain crystals of
protein–ligand complexes: cocrystallization and soaking.
The rationale for cocrystallization is that the protein is
more likely to bind a ligand in solution than in a crystal
where the packing and crystallization interactions might
limit or obstruct the formation of the protein–ligand com-
plex. Cocrystallization is certainly the technique of choice
when the interacting ligand is a macromolecule that is not
able to penetrate the crystal for sterical reasons or when
ligand binding induces large protein conformational chan-
ges. It is also routinely used when only a few interacting
partners are studied. However, cocrystallization is poorly
suited for extensive ligand–protein binding studies. In
many instances, the presence of an additional component in
the crystallization solution alters the conditions at which
crystals form even when ligand does not bind to the protein
in an ordered way. This effect worsens as the concentration
of the added component increases. It necessitates searching
for a new optimal crystallization condition, making the
overall study much more resource-intensive.
Soaking implies that the ligand diffuses into pregrown
and, possibly, stabilized crystals of the apo-form of the
protein and interacts with the binding site, which is not
constrained by crystal contacts. By soaking protein crystals
in cocktails of multiple ligands, more compounds may
be screened with the same number of crystals, further
increasing the throughput. Indeed, crystallographic
screening of chemical libraries is now employed in frag-
ment-based lead discovery in drug design for detecting the
binding of low afﬁnity, low molecular weight compounds
[47]. The screening is commonly done with soaks con-
taining from four to ten compounds in millimolar
concentrations, which enable binding of even low afﬁnity
ligands. The desirable outcome of the cocktail soak
screening is the presence of additional electron density
followed by direct identiﬁcation of the bound ligand from
the soaked structure. The chances of correct ligand iden-
tiﬁcation increase as the crystals diffract to higher resolu-
tion, the ligand occupancy is higher, and as the different
ligands present in the cocktail differ signiﬁcantly in
molecular shape or possess distinct functional groups that
can be identiﬁed through interaction with the protein.
Cocktail components can be more directly detected and
identiﬁed in a structure by the introduction of atoms pro-
viding an anomalous signal.
The throughput of crystal screening can be signiﬁcantly
increased with automation. Cocktail approach requires the
collection of many more datasets on many more crystals
than in the primary structure determination process.
Accordingly, the use of synchrotron radiation and robot-
assisted mounting becomes even more important. The
solution of the soaked structures is usually straightforward
since the space group and unit cell dimensions are typically
very similar to that of the apo-form of the crystal. In HKL-
3000, data processing is followed by map generation using
phases from the model of the native protein, or if there are
changes in the crystal form, by full molecular replacement
(MR) by MOLREP [39]. This is coupled with a module
that semiautomatically analyzes the ﬁt of the soak com-
ponents into any unexplained electron density regions
using the predeﬁned set of the cocktail component struc-
tures (Fig. 3a). The analysis, which is done by RESOLVE
[48], produces a set of ligand structures ranked according
to their ﬁt to the density [49]. Figure 3 illustrates the
application of the ligand analysis module to the identiﬁ-
cation of an unidentiﬁed component bound to the structure
of APC7551, a universal stress protein from Archaeoglobus
fulgidus, which was soaked in a cocktail of ten compounds.
The module properly identiﬁed the bound ligand as
cytidine-50-diphosphate (CDP) (Fig. 3b), which has a better
correlation with the electron density than the other com-
ponents of the soak, such as trehalose (Fig. 3c). The scores
showing the quality of the ﬁt of each compound to the
unknown density are shown in Fig. 3d. Other compounds
have very similar quality of ﬁt scores to CDP, such as
cytidine-50-monophosphate (CMP) and cytidine, which is
to be expected given their chemical similarity. In this case,
determining which compound has the best ﬁt (CDP, CMP
or cytidine) requires manual visual inspection of the ligand
models. (A different cocktail design better suited for
uniquely identifying the best binding compound would
have used a set of more dissimilar reagents.) Our experi-
ence shows that this human intervention is almost always
required, because ligand assignment can be impeded by
conformational changes in the protein or partial disorder in
the ligand structure.
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The modern reﬁnement process is highly automated,
especially for structures determined at resolution 2.5 A ˚ or
better. However, manual inspection of the map should be a
compulsory practice for every protein structure ready for
deposition. Parameters like R, Rfree, clashscore [41], and
Ramachandran plot statistics describe only the global cor-
rectness and quality of the structure. Flexible parts of the
protein can be identiﬁed by high values of the displacement
parameter (B-factor), and usually require manual correc-
tion. Small errors in mobile parts of the protein may not
signiﬁcantly affect global statistics but may be important
for interpretation of the structure–function relationship.
Similarly, the use of automatic procedures for identiﬁcation
and reﬁnement of ligands requires manual inspection and
veriﬁcation even for relatively high resolution structures.
Automaticproceduresquiteoftenfail toproperly identify
and reﬁne metal ions, but their proper identiﬁcation is very
important. Around 20% of all PDB deposits report the
presence of ordered metal ions adjacent to sites important
forthe biological activity ofthe macromolecule. Analysisof
the PDB shows that for medium resolution data (2.0–2.5 A ˚),
the environments of many zinc ions are not identiﬁed or
reﬁned properly (Fig. 4). In many cases, identiﬁcation and/
or reﬁnement of the metal binding sites are clearly incorrect
[50], when compared to very high resolution structures in
the Cambridge Structural Database [51]. PDB deposits do
not contain any information about the procedures that were
used to identify and reﬁne metal ions, but rarely are anom-
alous data from an additional experiment at the appropriate
wavelength used to identify possible metal ions unambigu-
ously. Similarly, the drive to automate the process of elec-
tron density map interpretation has increased the number of
deposits that contain unidentiﬁed small molecule agents.
The fraction of structures with clearly marked unknown
ligands is higher for higher resolution structures [52], as it is
more difﬁcult to place an erroneous arbitrary ligand into a
high resolution map.
Regardless of the degree of automation, the ﬁnal struc-
ture quality should be carefully assessed by a human being.
What quality statistics we should expect? When a structure
is reﬁned with HKL-3000, the experimenter can, at any
point of the reﬁnement procedure, compare the statistics of
the current reﬁnement with the average R and geometry
statistics derived from recent PDB deposits in the same
resolution range [53, 54]. The HKL-3000 reﬁnement
module also shows structure quality guidelines agreed
between the NIAID Infectious Diseases SG centers,
namely the Seattle Structural Genomics Center for Infec-
tious Disease (SSGCID) [55] and the CSGID [56]. These
guidelines mandate that the structure meet quality criteria
Fig. 3 Application of the
ligand analysis module in HKL-
3000 to the study of ligand
binding properties of APC7551,
a universal stress protein from
Archaeoglobus fulgidus. A The
module interface that describes
the soak composition. B The
bound component of the soak
cocktail, CDP, is automatically
ﬁt into the additional electron
density (2Fo - Fc is blue,
Fo - Fc is green). C Aﬁ to fa n
incorrect component of the soak
cocktail, trehalose, into the
same density. D A scoring
diagram that describes the ﬁt of
the soak components into
electron density (CDP
is number 5, trehalose is
number 9)
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123stricter than those derived from recent PDB structures
(http://www.csgid.org/csgid/cake/pages/sg_metrics). HKL-
3000 also uses Molprobity for validation of model geom-
etry, and in addition, a tool is provided that can remove
excessive waters based on their B-factor distribution
compared to the average B-factor for the structure under
reﬁnement. The expected number of waters for structures
of similar size and resolution can also be used as a refer-
ence (Fig. 5).
The handling of water molecules in HKL-3000 is an
example of an automatic procedure well integrated into the
semiautomatic reﬁnement process performed with Refmac
[40] and its use can sometimes signiﬁcantly improve the
structure quality. Sometimes, the reprocessing of raw dif-
fraction data and rereﬁnement of already deposited struc-
tures not only improves reﬁnement statistics, but may lead
to better identiﬁcation of structural details [57] and more
complete models (Fig. 6). In an ideal world, a signiﬁcantly
improved model should be redeposited in the PDB.
Although most software developers implement signiﬁcant
improvement of reﬁnement procedures, the number of
redeposited structures is below 2% of newly deposited
structures, as shown by analysis of the PDB.
There is one process that seems to be easy to automate,
but several attempts to fully automate the process of
deposition and validation of protein models and crystallo-
graphic experimental parameters have failed, including one
attempted by MCSG. There is a rising gap between the
growing number of protein models and the ability to pro-
cess and analyze the resulting data in a complex way. The
attempt to analyze even simple ﬁelds in the PDB header,
such as the temperature of crystallization, shows that
existing data are not fully reliable [58]. The recent retrac-
tion of 11 fraudulent PDB deposits [59] shows the neces-
sity for uniform validation of protein models and uniform
validation of experiments that lead to structure solution.
Also needed is wider accessibility of raw data in the form
of diffraction images—at the moment, only certain groups
like the CSGID and the Joint Center for Structural
Genomics (JCSG) have a policy of making diffraction
images publicly available. The lack of raw data and uni-
form validation tools makes global analysis of the PDB
very difﬁcult, as the creation of database from data sub-
mitted into PDB requires curation and editing of impossi-
ble values and resolution of many inconsistencies. The
creation of uniform, automatic validation tools would
simplify the work of journal referees.
Conclusions
It is obvious that automation of any single step of the
structure determination pipeline is capable of saving a sig-
niﬁcant amount of time for the experimenter and enabling
theprocesstoberuninahigh-throughputmanner.However,
theadvantageconferredbyautomationofasinglestepinthe
multi-step process may be greatly diminished if the auto-
mated step is not tightly integrated with other parts of the
structure determination pipeline. A series of incremental
improvements generates a multiplicative gain in efﬁciency;
so high output is the result of overall efﬁciency rather than
very high efﬁciency of one individual step.
The use of a single general protocol for cloning,
expression, puriﬁcation and crystallization of challenging
proteins will leave too many structures unsolved [52].
Likewise, an opposite approach, namely the development
and application of a customized and separate protocol for
every single protein, makes both high throughput and high
output impossible goals. Any automation approach must
have high throughput (output), but be ﬂexible enough to
handle multiple protocols.
There are several excellent systems that handle almost
whole process from crystal to deposit like PHENIX [60],
AUTOSHARP [61], SOLVE/RESOLVE [48], ANTS [62],
ELVES [63], CCP4 [32] or AUTORICKSHAW [64]. In
our (admittedly biased) opinion, HKL-3000 is the most
complete system, integrated with crystallization, protein
production and other relevant databases. Analysis of the
PDB shows that HKL-3000 was used in the solution of
over 1,000 PDB structures, solved both by SAD/MAD and
MR techniques, which indicates its robustness.
Fig. 4 Distributions of Zn-to-water-oxygen distances in the Cam-
bridge Structural Database (CSD, red), a set of high resolution PDB
structures (\1.5 A ˚), and a set of medium resolution PDB structures
(2.0–2.5 A ˚)
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high throughput of structural genomics. However, high
throughputdoesnotalwaystranslateintohighoutput.AsSG
efforts increasingly focus on more difﬁcult projects that
require more ﬂexible protocols, the automation pipeline
requires expert intervention at critical decision points. The
most successful approach is the development and automa-
tion of a multi-path approach that combines diversiﬁed
protocolsintoanintegratedandveryefﬁcient expertsystem.
Acknowledgments The authors would like to thank Zbyszek Dauter
and Alex Wlodawer for valuable discussions; and Heping Zheng and
Marcin Domagalski for help with generating statistics. The work
described in the paper was supported by GM74942, GM53163 and
with Federal funds from the National Institute of Allergy and Infec-
tious Diseases, National Institutes of Health, Department of Health
and Human Services, under Contract No. HHSN272200700058C.
This work was supported in part by the U.S. Department of Energy,
Ofﬁce of Biological and Environmental Research and Ofﬁce of Basic
Energy Sciences, under contract DE-AC02-06CH11357.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE,
Burkhardt K, Feng Z, Gilliland GL, Iype L, Jain S, Fagan P,
Marvin J, Padilla D, Ravichandran V, Schneider B, Thanki N,
Weissig H, Westbrook JD, Zardecki C (2002) The protein data
bank. Acta Crystallogr D Biol Crystallogr 58:899–907
2. O’Toole N, Grabowski M, Otwinowski Z, Minor W, Cygler M
(2004) The structural genomics experimental pipeline: insights
from global target lists. Proteins 56:201–210
3. Wernimont A, Edwards A (2009) In situ proteolysis to generate
crystals for structure determination: an update. PLoS One
4:e5094
4. Aslanidis C, de Jong PJ (1990) Ligation-independent cloning
of PCR products (LIC-PCR). Nucleic Acids Res 18:6069–
6074
5. Dieckman L, Gu M, Stols L, Donnelly MI, Collart FR (2002)
High throughput methods for gene cloning and expression. Pro-
tein Expr Purif 25:1–7
6. Camper DV, Viola RE (2009) Fully automated protein puriﬁca-
tion. Anal Biochem 393:176–181
7. Steen J, Uhle ´n M, Hober S, Ottosson J (2006) High-throughput
protein puriﬁcation using an automated set-up for high-yield
afﬁnity chromatography. Protein Expr Purif 46:173–178
8. Kim Y, Dementieva I, Zhou M, Wu R, Lezondra L, Quartey P,
Joachimiak G, Korolev O, Li H, Joachimiak A (2004) Automa-
tion of protein puriﬁcation for structural genomics. J Struct Funct
Genomics 5:111–118
9. Viola R, Carman P, Walsh J, Frankel D, Rupp B (2007) Auto-
mated robotic harvesting of protein crystals-addressing a critical
bottleneck or instrumentation overkill? J Struct Funct Genomics
8:145–152
10. Viola R, Carman P, Walsh J, Miller E, Benning M, Frankel D,
McPherson A, Cudney B, Rupp B (2007) Operator-assisted har-
vesting of protein crystals using a universal micromanipulation
robot. J Appl Crystallogr 40:539–545
11. Manjasetty BA, Turnbull AP, Panjikar S, Bussow K, Chance MR
(2008) Automated technologies and novel techniques to accel-
erate protein crystallography for structural genomics. Proteomics
8:612–625
Fig. 5 The water molecule
validation window in HKL-
3000. A The original
distribution of water oxygen
atoms by B-factor in PDB
deposit 3EME. B The
distribution of water oxygen
atoms by B-factor after structure
rereﬁnement
Fig. 6 Rereﬁnement of PDB
structure 3BQS. A Electron
density and model of 3BQS as
reported in the PDB. B The
same electron density region
after re-reﬁnement with HKL-
3000 and redeposition as 3MAB
To automate or not to automate 219
12312. Zimmerman MD, Chruszcz M, Koclega KD, Otwinowski Z,
Minor W (2005) The Xtaldb system for project salvaging in high-
throughput crystallization. Acta Cryst A 61:c178–c179
13. Lesley SA, Wilson IA (2005) Protein production and crystalli-
zation at the joint center for structural genomics. J Struct Funct
Genomics 6:71–79
14. Newman J, Egan D, Walter TS, Meged R, Berry I, Ben Jelloul M,
Sussman JL, Stuart DI, Perrakis A (2005) Towards rationalization
of crystallization screening for small- to medium-sized academic
laboratories: the PACT/JCSG?strategy. Acta Crystallogr D Biol
Crystallogr 61:1426–1431
15. Dong A, Xu X, Edwards AM, Chang C, Chruszcz M, Cuff M,
Cymborowski M, Di Leo R, Egorova O, Evdokimova E,
Filippova E, Gu J, Guthrie J, Ignatchenko A, Joachimiak A,
Klostermann N, Kim Y, Korniyenko Y, Minor W, Que Q,
Savchenko A, Skarina T, Tan K, Yakunin A, Yee A, Yim V,
Zhang R, Zheng H, Akutsu M, Arrowsmith C, Avvakumov
GV, Bochkarev A, Dahlgren LG, Dhe-Paganon S, Dimov S,
Dombrovski L, Finerty P Jr, Flodin S, Flores A, Graslund S,
Hammerstrom M, Herman MD, Hong BS, Hui R, Johansson I,
Liu Y, Nilsson M, Nedyalkova L, Nordlund P, Nyman T, Min
J, Ouyang H, Park HW, Qi C, Rabeh W, Shen L, Shen Y,
Sukumard D, Tempel W, Tong Y, Tresagues L, Vedadi M,
Walker JR, Weigelt J, Welin M, Wu H, Xiao T, Zeng H, Zhu
H (2007) In situ proteolysis for protein crystallization and
structure determination. Nat Methods 4:1019–1021
16. Kim Y, Quartey P, Li H, Volkart L, Hatzos C, Chang C, Nocek B,
Cuff M, Osipiuk J, Tan K, Fan Y, Bigelow L, Maltseva N, Wu R,
Borovilos M, Duggan E, Zhou M, Binkowski TA, Zhang RG,
Joachimiak A (2008) Large-scale evaluation of protein reductive
methylation for improving protein crystallization. Nat Methods
5:853–854
17. Walter TS, Meier C, Assenberg R, Au KF, Ren J, Verma A,
Nettleship JE, Owens RJ, Stuart DI, Grimes JM (2006) Lysine
methylation as a routine rescue strategy for protein crystalliza-
tion. Structure 14:1617–1622
18. McPherson A, Cudney B (2006) Searching for silver bullets: an
alternative strategy for crystallizing macromolecules. J Struct
Biol 156:387–406
19. Derewenda ZS, Vekilov PG (2006) Entropy and surface engi-
neering in protein crystallization. Acta Crystallogr D Biol Crys-
tallogr 62:116–124
20. Chruszcz M, Wlodawer A, Minor W (2008) Determination of
protein structures—a series of fortunate events. Biophys J 95:1–9
21. Soltis SM, Cohen AE, Deacon A, Eriksson T, Gonzalez A,
McPhillips S, Chui H, Dunten P, Hollenbeck M, Mathews I,
Miller M, Moorhead P, Phizackerley RP, Smith C, Song J, van
dem Bedem H, Ellis P, Kuhn P, McPhillips T, Sauter N, Sharp K,
Tsyba I, Wolf G (2008) New paradigm for macromolecular
crystallography experiments at SSRL: automated crystal screen-
ing and remote data collection. Acta Crystallogr D Biol Crys-
tallogr 64:1210–1221
22. Okazaki N, Hasegawa K, Ueno G, Murakami H, Kumasaka T,
Yamamoto M (2008) Mail-in data collection at SPring-8 protein
crystallography beamlines. J Synchrotron Radiat 15:288–291
23. Robinson H, Soares AS, Becker M, Sweet R, Heroux A (2006)
Mail-in crystallography program at brookhaven national labora-
tory’s national synchrotron light source. Acta Crystallogr D Biol
Crystallogr 62:1336–1339
24. Muchmore SW, Olson J, Jones R, Pan J, Blum M, Greer J,
Merrick SM, Magdalinos P, Nienaber VL (2000) Automated
crystal mounting and data collection for protein crystallography.
Structure 8:R243–R246
25. Cork C, O’Neill J, Taylor J, Earnest T (2006) Advanced beamline
automation for biological crystallography experiments. Acta
Crystallogr D Biol Crystallogr 62:852–858
26. Snell G, Cork C, Nordmeyer R, Cornell E, Meigs G, Yegian D,
Jaklevic J, Jin J, Stevens RC, Earnest T (2004) Automated sample
mounting and alignment system for biological crystallography at
a synchrotron source. Structure 12:537–545
27. Cusack S, Belrhali H, Bram A, Burghammer M, Perrakis A,
Riekel C (1998) Small is beautiful: protein micro-crystallogra-
phy. Nat Struct Biol 5(Suppl):634–637
28. Pohl E, Ristau U, Gehrmann T, Jahn D, Robrahn B, Malthan D,
Dobler H, Hermes C (2004) Automation of the EMBL hamburg
protein crystallography beamline BW7B. J Synchrotron Radiat
11:372–377
29. Vernede X, Lavault B, Ohana J, Nurizzo D, Joly J, Jacquamet L,
Felisaz F, Cipriani F, Bourgeois D (2006) UV laser-excited ﬂuo-
rescence as a tool for the visualization of protein crystals mounted
in loops. Acta Crystallogr D Biol Crystallogr 62:253–261
30. Dauter Z (2005) Efﬁcient use of synchrotron radiation for mac-
romolecular diffraction data collection. Prog Biophys Mol Biol
89:153–172
31. Minor W, Cymborowski M, Otwinowski Z, Chruszcz M (2006)
HKL-3000: the integration of data reduction and structure solu-
tion–from diffraction images to an initial model in minutes. Acta
Crystallogr D Biol Crystallogr 62:859–866
32. CCP4 (1994) The CCP4 suite: programs for protein crystallog-
raphy. Acta Crystallogr D Biol Crystallogr 50:760–763
33. Terwilliger TC, Berendzen J (1999) Automated MAD and MIR
structure solution. Acta Crystallogr D Biol Crystallogr 55:
849–861
34. Terwilliger TC (2003) Automated main-chain model building by
template matching and iterative fragment extension. Acta Crys-
tallogr D Biol Crystallogr 59:38–44
35. Otwinowski Z (1991) ML-PHARE. in CCP4, SERC Daresbury
Laboratory, Warrington, UK
36. Sheldrick G (2008) A short history of SHELX. Acta Crystallogr
A 64:112–122
37. Perrakis A, Morris R, Lamzin VS (1999) Automated protein
model building combined with iterative structure reﬁnement. Nat
Struct Biol 6:458–463
38. Cowtan K (1994) DM: an automated procedure for phase
improvement by density modiﬁcation. Joint CCP4 and ESF-
EACBM Newsletter on Protein Crystallogr 31:34–38
39. Vagin A, Teplyakov A (1997) MOLREP: an automatic program
for molecular replacement. J Appl Cryst 30:1022–1025
40. Murshudov GN, Vagin AA, Dodson EJ (1997) Reﬁnement of
macromolecular structures by the maximum-likelihood method.
Acta Crystallogr D Biol Crystallogr 53:240–255
41. Davis IW, Leaver-Fay A, Chen VB, Block JN, Kapral GJ, Wang
X, Murray LW, Arendall WB III, Snoeyink J, Richardson JS,
Richardson DC (2007) MolProbity: all-atom contacts and struc-
ture validation for proteins and nucleic acids. Nucleic Acids Res
35:W375–W383
42. Koclega KD, Chruszcz M, Zimmerman MD, Cymborowski M,
Evdokimova E, Minor W (2007) Crystal structure of a tran-
scriptional regulator TM1030 from Thermotoga maritima solved
by an unusual MAD experiment. J Struct Biol 159:424–432
43. Long F, Vagin AA, Young P, Murshudov GN (2008) BALBES: a
molecular-replacement pipeline. Acta Crystallogr D Biol Crys-
tallogr 64:125–132
44. Keegan RM, Winn MD (2008) MrBUMP: an automated pipeline
for molecular replacement. Acta Crystallogr D Biol Crystallogr
64:119–124
45. Lebedev AA, Vagin AA, Murshudov GN (2008) Model prepa-
ration in MOLREP and examples of model improvement using
X-ray data. Acta Crystallogr D Biol Crystallogr 64:33–39
46. Schwarzenbacher R, Godzik A, Jaroszewski L (2008) The JCSG
MR pipeline: optimized alignments, multiple models and parallel
searches. Acta Crystallogr D Biol Crystallogr 64:133–140
220 M. Cymborowski et al.
12347. Nienaber VL, Richardson PL, Klighofer V, Bouska JJ, Giranda
VL, Greer J (2000) Discovering novel ligands for macromole-
cules using X-ray crystallographic screening. Nat Biotechnol
18:1105–1108
48. Terwilliger T (2004) SOLVE and RESOLVE: automated struc-
ture solution, density modiﬁcation and model building. J Syn-
chrotron Radiat 11:49–52
49. Terwilliger TC, Adams PD, Moriarty NW, Cohn JD (2007)
Ligand identiﬁcation using electron-density map correlations.
Acta Crystallogr D Biol Crystallogr 63:101–107
50. Zheng H, Chruszcz M, Lasota P, Lebioda L, Minor W (2008)
Data mining of metal ion environments present in protein struc-
tures. J Inorg Biochem 102:1765–1776
51. Allen FH, Taylor R (2004) Research applications of the cam-
bridge structural database (CSD). Chem Soc Rev 33:463–475
52. Grabowski M, Chruszcz M, Zimmerman MD, Kirillova O, Minor
W (2009) Beneﬁts of structural genomics for drug discovery
Research. Infect Disord Drug Targets 9:459–474
53. Read RJ, Kleywegt GJ (2009) Case-controlled structure valida-
tion. Acta Crystallogr D Biol Crystallogr 65:140–147
54. Urzhumtseva L, Afonine PV, Adams PD, Urzhumtsev A (2009)
Crystallographic model quality at a glance. Acta Crystallogr D
Biol Crystallogr 65:297–300
55. Myler PJ, Stacy R, Steward L, Staker B, Van Voorhis WC,
Varani G, Buchko GW (2009) The seattle structural genomics
center for infectious disease (SSGCID). Infect Disord Drug
Targets 9:493–506
56. Anderson WF (2009) Structural genomics and drug discovery for
infectious diseases. Infect Disord Drug Targets 9:507–517
57. Joosten RP, Womack T, Vriend G, Bricogne G (2009) Re-
reﬁnement from deposited X-ray data can deliver improved
models for most PDB entries. Acta Crystallogr D Biol Crystallogr
65:176–185
58. Koclega KD, Chruszcz M, Zimmerman MD, Bujacz G, Minor W
(2010) ‘Hot’ macromolecular crystals. Cryst Growth Des 10:
580–586
59. Borrell B (2009) Fraud rocks protein community. Nature 462:970
60. Adams PD, Gopal K, Grosse-Kunstleve RW, Hung LW, Ioerger
TR, McCoy AJ, Moriarty NW, Pai RK, Read RJ, Romo TD,
Sacchettini JC, Sauter NK, Storoni LC, Terwilliger TC (2004)
Recent developments in the PHENIX software for automated
crystallographic structure determination. J Synchrotron Radiat
11:53–55
61. Vonrhein C, Blanc E, Roversi P, Bricogne G (2007) Automated
structure solution with autoSHARP. Methods Mol Biol 364:
215–230
62. Brunzelle JS, Shafaee P, Yang X, Weigand S, Ren Z, Anderson
WF (2003) Automated crystallographic system for high-
throughput protein structure determination. Acta Crystallogr D
Biol Crystallogr 59:1138–1144
63. Holton J, Alber T (2004) Automated protein crystal structure
determination using ELVES. Proc Natl Acad Sci USA 101:1537–
1542
64. Panjikar S, Parthasarathy V, Lamzin VS, Weiss MS, Tucker PA
(2005) Auto-Rickshaw: an automated crystal structure determi-
nation platform as an efﬁcient tool for the validation of an X-ray
diffraction experiment. Acta Crystallogr D Biol Crystallogr
61:449–457
To automate or not to automate 221
123